Literature DB >> 17894832

Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis.

E Laspa1, A Christen, Z Efstathiadou, D G Johnston, I F Godsland.   

Abstract

AIMS: To determine whether rate of change and variability in risk factors provides insight into the development of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or Type 2 diabetes (DM).
METHODS: In a nested case-control study, repeated risk factor measurements (mean number 4.3, duration 11.4 years) culminated in 59 men developing IFG (n = 37), IGT (n = 14) and/or DM (n = 11). For each case, two control subjects were matched for age and equivalence of follow-up. Rates of change and variability in diabetes risk factors prior to diagnosis were quantified by regression analysis. Changes between penultimate and diagnostic visits were also analysed.
RESULTS: The age-related rise in body mass index (BMI) was attenuated prior to IFG compared with control subjects (+0.102 vs. +0.772 kg/m2/decade, P = 0.02). There was also some evidence for this prior to IGT and DM (IGT: -1.530 vs. +0.158 kg/m2/decade, P = 0.09; DM: -1.146 vs. +0.332 kg/m2/decade, non-significant). Prior to onset, IGT cases were distinguished by higher inflammatory marker levels, a decline in insulinogenic index and greater variability in oral glucose tolerance test (OGTT) insulin, and DM cases by lower insulin sensitivity and higher liver enzyme activities. Fasting and OGTT glucose levels changed little during the mean 8.9 years prior to onset of IFG, IGT or DM. The transition to IGT or DM was accompanied by a fall in insulin sensitivity.
CONCLUSIONS: Except for BMI, change or variability in risk factor levels appears relatively unimportant in the development of clinically elevated glucose levels. Deterioration in glucose levels to IGT or DM occurs as a rapid, incremental increase accompanied by a decline in insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17894832     DOI: 10.1111/j.1464-5491.2007.02225.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

2.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

3.  Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study.

Authors:  Alain Gautier; Ronan Roussel; Céline Lange; Xavier Piguel; Stéphane Cauchi; Sylviane Vol; Philippe Froguel; Beverley Balkau; Fabrice Bonnet
Journal:  Diabetes       Date:  2011-09-12       Impact factor: 9.461

4.  Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7).

Authors:  Yoriko Heianza; Yasuji Arase; Kazuya Fujihara; Shiun Dong Hsieh; Kazumi Saito; Hiroshi Tsuji; Satoru Kodama; Naoya Yahagi; Hitoshi Shimano; Nobuhiro Yamada; Shigeko Hara; Hirohito Sone
Journal:  Diabetes Care       Date:  2012-03-28       Impact factor: 19.112

5.  Trajectories of Postload Plasma Glucose in the Development of Type 2 Diabetes in Japanese Adults.

Authors:  Rie Oka; Kyoko Shibata; Masaru Sakurai; Mitsuhiro Kometani; Masakazu Yamagishi; Kenichi Yoshimura; Takashi Yoneda
Journal:  J Diabetes Res       Date:  2017-09-14       Impact factor: 4.011

6.  Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study.

Authors:  G Hulsegge; A M W Spijkerman; Y T van der Schouw; S J L Bakker; R T Gansevoort; H A Smit; W M M Verschuren
Journal:  Nutr Diabetes       Date:  2017-05-08       Impact factor: 5.097

7.  Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.

Authors:  Adam Hulman; Rebecca K Simmons; Eric J Brunner; Daniel R Witte; Kristine Færch; Dorte Vistisen; Satoyo Ikehara; Mika Kivimaki; Adam G Tabák
Journal:  Diabetologia       Date:  2017-04-13       Impact factor: 10.122

Review 8.  New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes.

Authors:  Lingwen Gu; Guofeng Ma; Cui Li; Jing Lin; Guiqiu Zhao
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

9.  Hepatic Steatosis and High-Normal Fasting Glucose as Risk Factors for Incident Prediabetes.

Authors:  Toru Aizawa; Yasuto Nakasone; Norimitsu Murai; Rie Oka; Shoichiro Nagasaka; Koh Yamashita; Takahiro Sakuma; Kendo Kiyosawa
Journal:  J Endocr Soc       Date:  2022-07-31

10.  Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study.

Authors:  Quoc Manh Nguyen; Sathanur R Srinivasan; Ji-Hua Xu; Wei Chen; Gerald S Berenson
Journal:  Diabetes Care       Date:  2008-07-15       Impact factor: 17.152

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.